Immunoglobulin Treatment - FOI Response Register

1. In the past 3 months, how many patients have received the following treatments (for any disease)?

•           Berinert (Human C1-esterase inhibitor)  ZERO

•           Cinryze (Human C1-esterase inhibitor) ZERO

•           Firazyr (Icatibant) ZERO

•           Icatibant - any brand except Firazyr ZERO

•           Orladeyo (Berotralstat) ZERO

•           Ruconest (Recombinant human C1-esterase inhibitor)  ZERO

•           Takhzyro (Lanadelumab)  ZERO

2. In the past 3 months, how many patients have received the following immunoglobulin treatments (for any disease)?

•           Cutaquig                  ZERO

•           Cuvitru                       ZERO

•           Gammagard              ZERO

•           Gammanorm             ZERO

•           Hizentra                     ZERO

•           Hyqvia                        ZERO

•           Intratect                      ZERO

•           Iqymune                     ZERO

•           Kiovig                         <5

•           Privigen                     <5

•           Octagam                    ZERO

•           Panzyga                    ZERO

•           Subgam                     ZERO

•           Any other normal immunoglobulin ZERO

Where we have given < 5 answers this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38 (1) (b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.